Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.67 |
| ▸ | RPS6KA5 | O75582 | 12/20 | 0.65 |
| ▸ | ROCK1 | Q13464 | 10/20 | 0.65 |
| ▸ | AKT1 | P31749 | 10/20 | 0.65 |
| ▸ | AKT2 | P31751 | 6/20 | 0.65 |
| ▸ | AKT3 | Q9Y243 | 5/20 | 0.65 |
| ▸ | RPS6KA1 | Q15418 | 5/20 | 0.65 |
| ▸ | ROCK2 | O75116 | 2/20 | 0.65 |
| ▸ | GSK3A | P49840 | 2/20 | 0.65 |
| ▸ | PRKACA | P17612 | 2/20 | 0.65 |
| ▸ | GSK3B | P49841 | 2/20 | 0.65 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.65 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.65 |
| ▸ | PIM1 | P11309 | 1/20 | 0.65 |
| ▸ | MARK3 | P27448 | 1/20 | 0.65 |
| ▸ | GRK5 | P34947 | 1/20 | 0.65 |
| ▸ | CDK8 | P49336 | 1/20 | 0.65 |
| ▸ | CLK2 | P49760 | 1/20 | 0.65 |
| ▸ | CDK7 | P50613 | 1/20 | 0.65 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4071938 | 0.92 | SLC2A1 (0.67) | SLC2A1RPS6KA5ROCK1AKT1AKT2 | |
| SCHEMBL4069258 | 0.91 | SLC2A1 (0.66) | SLC2A1RPS6KA5ROCK1AKT1AKT2 | |
| SCHEMBL4066664 | 0.90 | SLC2A1 (0.65) | SLC2A1RPS6KA5ROCK1AKT1AKT2 | |
| SCHEMBL4072487 | 0.90 | SLC2A1 (0.63) | SLC2A1RPS6KA5ROCK1AKT1AKT2 | |
| SCHEMBL4062927 | 0.89 | SLC2A1 (0.70) | SLC2A1RPS6KA5ROCK1AKT1AKT2 | |
| SCHEMBL4062933 | 0.88 | RPS6KA5 (0.67) | SLC2A1RPS6KA5ROCK1AKT1AKT2 | |
| Trifluoroacetic Acid SCHEMBL5067496 | 0.87 | SLC2A1 (0.75) | SLC2A1RPS6KA5ROCK1AKT1AKT2 | |
| SCHEMBL4066991 | 0.87 | RPS6KA5 (0.68) | SLC2A1RPS6KA5ROCK1AKT1AKT2 | |
| Trifluoroacetic Acid SCHEMBL5062811 | 0.87 | SLC2A1 (0.74) | SLC2A1RPS6KA5ROCK1AKT1AKT2 | |
| SCHEMBL4071540 | 0.87 | SLC2A1 (0.66) | SLC2A1RPS6KA5ROCK1AKT1AKT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1653961-A4 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORP (US) | 2009-04-01 | — | — | EP | claimed |
| US-20080255143-A1 | Inhibitors of Akt Activity | SMITHKLINE BEECHAM CORPORATION (PA) | 2008-10-16 | — | — | US | claimed |
| EP-1653961-A1 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORPORATION (US) | 2006-05-10 | — | — | EP | claimed |
| WO-2005011700-A1 | INHIBITORS OF Akt ACTIVITY | SMITHKLINE BEECHAM CORPORATION (US) | 2005-02-10 | — | — | WO | claimed |
| EP-1653961-A4 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORP (US) | 2009-04-01 | — | — | EP | disclosed |
| US-20080255143-A1 | Inhibitors of Akt Activity | SMITHKLINE BEECHAM CORPORATION (PA) | 2008-10-16 | — | — | US | disclosed |
| EP-1653961-A1 | INHIBITORS OF AKT ACTIVITY | SMITHKLINE BEECHAM CORPORATION (US) | 2006-05-10 | — | — | EP | disclosed |
| WO-2005011700-A1 | INHIBITORS OF Akt ACTIVITY | SMITHKLINE BEECHAM CORPORATION (US) | 2005-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255143-A1 | Inhibitors of Akt Activity | PI4KB, PIK3CA, AKT2 | SLC2A1 3039/4885RPS6KA5 156/4885ROCK1 478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.